Disc Medicine, Inc.
IRON
Clasificación en acciones
#4958
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a... Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Precio por acción
$75.39
Última sincronización: 2026-10-22
Capitalización bursátil
$2.89B
Cambio (1 día)
-0.80%
Cambio (1 año)
-9.92%
País
US
Comercio Disc Medicine, Inc. (IRON)
Categoría
Healthcare
Ratio P/B de Disc Medicine, Inc. (IRON)
Ratio P/B al October 2026 TTM: 4.65
Según los informes financieros más recientes y el precio de las acciones de Disc Medicine, Inc., el ratio P/B actual (TTM) es 4.65. Al final de 2024, el ratio P/B era 3.95.
Historial del ratio P/B de Disc Medicine, Inc. desde 2020 hasta 2026
Ratio P/B al final de cada año
| Año | Ratio P/B | Cambiar |
|---|---|---|
| 2026 (TTM) | 4.65 | 22.73% |
| 2025 | 3.79 | -3.98% |
| 2024 | 3.95 | 5.64% |
| 2023 | 3.73 | 3,089.41% |
| 2022 | 0.12 | -132.23% |
| 2021 | -0.36 | -95.22% |
| 2020 | -7.61 | 0.00% |
Ratio P/B de empresas similares o competidoras
| Empresa | Ratio P/B | Diferencia del ratio P/B | País |
|---|---|---|---|
| 6.6964 | 43.96% |
US
|
|
| 13.6307 | 193.03% |
US
|
|
| 4.4521 | -4.29% |
AU
|
|
| 4.2241 | -9.19% |
BE
|
|
| 6.3632 | 36.80% |
NL
|
